NCT00262990 2020-12-17
Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal Cancer
Novartis
Phase 3 Completed
Clinical Trials
13 trialsNCT00420524 2020-12-09
A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function
Novartis
Phase 1 Completed
NCT00426582 2020-12-09
Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors
Novartis
Phase 1 Completed
NCT00420615 2020-12-08
Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies
Novartis
Phase 1 Completed
NCT00050349 2017-03-01
EPO906 in Carcinoid and Other Neuroendocrine Tumors
Novartis
Phase 2 Completed
NCT00035113 2017-02-09
EPO906 Therapy in Patients With Prostate Cancer
Novartis
Phase 2 Completed
NCT00035087 2013-12-04
EPO906 Therapy in Patients With Advanced Colorectal Cancer
Novartis
Phase 2 Completed
NCT00496600 2012-06-14
Phase I Study of Patupilone and RAD001
Rutgers, The State University of New Jersey
Phase 1 Completed
NCT00442741 2012-04-25
Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (Extension)
Novartis
Phase 1 Withdrawn
NCT00421044 2012-01-11
A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function
Novartis
Phase 1 Completed
NCT00412789 2010-05-31
Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan
Novartis
Phase 1 Completed
NCT00448396 2009-11-19
Evaluate the Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies
Novartis
Phase 1 Completed
NCT00468260 2009-11-19
The Effects of Patupilone on the Pharmacokinetics and Pharmacodynamics of Warfarin in Patients With Advanced Malignancies
Novartis
Phase 1 Terminated